Table 4.

Distribution of molecular types and different antibiotic resistant patterns in 101 MRSA isolates

spa type (N; %)	No. patients	No. HCWs	No. surfaces	SCCmec type	agr type	Resistance profile	No. isolates
t030 (57; 56.4)	40	5	12	III, I	I	GM, MUP, RP, E, CD, T, IM, PG, NOR	48
						NOR	2
						NOR, SXT, PG	7
t037 (26; 25.6)	23	1	2	III, I	I	GM, NOR, SXT, CD, E, PG, IM	16
						RP, MUP, GM, PG	4
						PG, IM, T, CD, E	6
t046 (3; 3)	3	0	0	I	I	E, CD, T, PG, IM, GM, MUP, RP, NOR	3
t4864 (2; 2)	2	0	0	III	II	IM, PG, SXT, NOR, E, T, GM	2
t091 (2; 2)	2	0	0	NT, III	II, I	E, CD, T, PG, GM, MUP, SXT	2
t789 (2; 2)	2	0	0	NT, I	III	C, PG, CD, E	2
t459 (1; 1), t16471 (1; 1)	1, 0	0, 1	0, 0	I, III	I	GM, MUP, RP, NOR, E, CD, T, PG, IM	2
t363 (1; 1)	1	0	0	IV	I	MUP, E, PG, IM	1
t3802 (1; 1), t304 (1; 1)	1, 1	0, 0	0, 0	NT, I	I	PG	2
t937 (1; 1)	1	0	0	I	II	PG, IM	1
t230 (1; 1)	1	0	0	IV	I	MUP, PG, IM	1
t3132 (1; 1), t701 (1; 1)	0, 1	0, 0	1, 0	I, III	II, I	GM, MUP, NOR, E, CD, T, PG, IM	2

C, chloramphenicol; CD, clindamycin; E, erythromycin; GM, gentamycin; IM, imipenem; MRSA, methicillin-resistant Staphylococcus aureus; MUP, mupirocin; NOR, norfloxacin; NT, nontypeable; PG, penicillin; RP, rifampicin; SXT, trimethoprim/sulfamethoxazole; T, tetracycline.